A theoretical analysis of interval drug dosing for cell-cycle-phase-specific drugs
- 1 April 1992
- journal article
- Published by Elsevier in Mathematical Biosciences
- Vol. 109 (1), 85-97
- https://doi.org/10.1016/0025-5564(92)90053-y
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- The Molecular Biology of Human Immunodeficiency Virus Type 1 InfectionNew England Journal of Medicine, 1991
- A Randomized Controlled Trial of a Reduced Daily Dose of Zidovudine in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1990
- Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expressionJournal of Virology, 1989
- Reduction of cytotoxicity to normal tissues by new regimens of cell-cycle phase-specific drugsMathematical Biosciences, 1988
- Induction of HTLV-III/LAV from a Nonvirus-Producing T-Cell Line: Implications for LatencyScience, 1986
- The importance of dose intensity in chemotherapy of metastatic breast cancer.Journal of Clinical Oncology, 1984
- Increased Tolerance of Leukemic Mice to Arabinosyl Cytosine with Schedule Adjusted to Circadian SystemScience, 1972
- Deoxyribonucleic Acid Synthesis Time of Erythropoietic and Granulopoietic Cells in Human BeingsNature, 1966